Topharman Shanghai
Topharman Shanghai, officially known as Topharman Pharmaceutical Co., Ltd., is a leading player in the pharmaceutical industry, headquartered in Shanghai, China. Founded in 2003, the company has established a strong presence in major operational regions across Asia and beyond, focusing on the development and manufacturing of high-quality pharmaceutical products. Specialising in innovative drug formulations and advanced delivery systems, Topharman is recognised for its commitment to research and development, which has led to several key milestones in the industry. The company’s core offerings include a diverse range of generic and specialty medications, distinguished by their efficacy and safety profiles. With a robust market position, Topharman has garnered numerous accolades for its contributions to healthcare, making it a trusted name among healthcare professionals and patients alike.
DitchCarbon Score
How does Topharman Shanghai's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Topharman Shanghai's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Topharman Shanghai's reported carbon emissions
Topharman Shanghai, headquartered in China, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. The absence of data may indicate a need for improved transparency in their environmental reporting. As the industry increasingly prioritises climate action, Topharman Shanghai's future commitments and strategies will be crucial in aligning with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Topharman Shanghai is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
